Author

P. Soubrié

Observed names: P P Soubrie, P SOUBRIE, P Soubrie, P Soubrié, P. H. Soubri??, P. SOUBRIE, P. SOUBRIÉ, P. Soubrie, P. Soubrie´, P. Soubriè, Ph. Soubrie, Ph. Soubrié

Observed institutions: Centre National de la Recherche Scientifique, University of Bonn, Inserm, Collège de France, Sanofi (France), Sorbonne Université, Sanofi (Italy), Pitié-Salpêtrière Hospital, National Institute of Mental Health, Études sur les Sciences et les Techniques, Laboratoire de Psychopathologie et Pharmacologie des Comportements, Neuropsychopharmacologie, UCLouvain

OpenAlex ID: A5110015986

The Cannabinoid CB1 Receptor Antagonist SR141716 Increases Acrp30 mRNA Expression in Adipose Tissue of Obese fa/fa Rats and in Cultured Adipocyte Cells

2003 · M. Bensaid, M. Gary-Bobo, et al. · Molecular Pharmacology · 593

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity

2004 · C Ravinet Trillou, C Delgorge, et al. · International Journal of Obesity · 583

SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats

2002 · C. Cohen, G. Perrault, et al. · Behavioural Pharmacology · 396

Blockade of CRF1 or V1b receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression

2003 · R Alonso, G Griebel, et al. · Molecular Psychiatry · 319

Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716

1996 · J. -P. Terranova, J. -J. Storme, et al. · Psychopharmacology · 283

SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset.

1998 · J Simiand, M Keane, et al. · PubMed · 265

SR 142801, The first potent non-peptide antagonist of the tachykinin NK3 receptor

1994 · X. Emonds-Alt, D. Bichon, et al. · Life Sciences · 218

Functional aspects of serotonin transmission in the basal ganglia: A review and in vivo approach using the push-pull cannula technique

1984 · P. Soubrié, T.D. Reisine, et al. · Neuroscience · 132

Decreased convulsant potency of picrotoxin and pentetrazol and enhanced [3H]flunitrazepam cortical binding following stressful manipulations in rats

1980 · P. Soubrie, M.H. Thiebot, et al. · Brain Research · 123

Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist.

1992 · M Rinaldi-Carmona, C Congy, et al. · Journal of Pharmacology and Experimental Therapeutics · 116

SSR591813, a Novel Selective and Partial α4β2 Nicotinic Receptor Agonist with Potential as an Aid to Smoking Cessation

2003 · C. Cohen, O.E. Bergis, et al. · Journal of Pharmacology and Experimental Therapeutics · 114

The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes

1994 · I. Dubuc, J. Costentin, et al. · British Journal of Pharmacology · 113

PDF

Activation of dopaminergic and cholinergic neurotransmission by tachykinin NK3 receptor stimulation: an in vivo microdialysis approach in guinea pig

1998 · N Marco, A Thirion, et al. · Neuropeptides · 105

Effects of imipramine-like drugs and serotonin uptake blockers on delay of reward in rats. Possible implication in the behavioral mechanism of action of antidepressants.

1988 · J C Bizot, M H Thiébot, et al. · Journal of Pharmacology and Experimental Therapeutics · 98

Attenuation of induced-anxiety in rats by chlordiazepoxide: Role of raphe dorsalis benzodiazepine binding sites and serotoninergic neurons

1982 · M.-H. Thiébot, M. Hamon, et al. · Neuroscience · 96

Shuttle-box deficits induced by inescapable shocks in rats: Reversal by the beta-adrenoreceptor stimulants clenbuterol and salbutamol

1986 · P. Martin, P. Soubrie, et al. · Pharmacology Biochemistry and Behavior · 86

SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission

1994 · R. Steinberg, P. Brun, et al. · Neuroscience · 85

Effect of nerve activity on the in vivo release of [3H]serotonin continuously formed from l-[3H]tryptophan in the caudate nucleus of the cat

1979 · F. He´nry, G. Simonnet, et al. · Brain Research · 85

Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D2 function

1999 · R Alonso, B Voutsinos, et al. · Neuroscience · 80

Involvement of lateral habenula-dorsal raphe neurons in the differential regulation of striatal and nigral serotonergic transmission cats

1982 · TD Reisine, P Soubrie, et al. · Journal of Neuroscience · 80

PDF

Effects of CB1 Cannabinoid Receptor Blockade on Ethanol Preference After Chronic Ethanol Administration

2001 · F. Lallemand, P. H. Soubri??, et al. · Alcoholism Clinical and Experimental Research · 78

SR141716, a CB1 receptor antagonist, decreases the sensitivity to the reinforcing effects of electrical brain stimulation in rats

2001 · V. Deroche-Gamonet, M. Le Moal, et al. · Psychopharmacology · 72

Protective effects of SR 57746A in central and peripheral models of neurodegenerative disorders in rodents and primates

1993 · J. Fournier, R. Steinberg, et al. · Neuroscience · 72

Chlordiazepoxide reduces in vivo serotonin release in the basal ganglia of encéphale isolé but not anesthetized cats: evidence for a dorsal raphe site of action.

1983 · P Soubrie, C Blas, et al. · Journal of Pharmacology and Experimental Therapeutics · 72

In vivo release of met-enkephalin in the cat brain

1981 · F. Cesselin, P. Soubrié, et al. · Neuroscience · 72

Works count: 139

Citation count: 6,761

H-index: 44

I10-index: 102